DELTA DIALOG

Emir Mustafa Isler
DELTA DIALOG

DELTA DIALOG is a series of discussions and interviews on AI and technology as in its development, usage in different sectors and industries, and how it engages or better said changes the world. Together with experts from diverse industries, the show explores many perspectives regarding AI and technology that has everyday implications around the world.

  1. 09/05/2024

    AI: Tool or Sentient Entity? - with Tomoko Mitsuoka and Emir Mustafa Isler

    Overview: In this episode of the Delta Dialog, Tomoko shares her insights into responsible AI development, the importance of educating the public on AI, and the challenges of balancing technological innovation with social values. Key Topics: 1. AI: Tool or Sentient Entity? Tomoko emphasizes that AI remains a tool, despite some users feeling as though they are interacting with sentient beings. AI generates responses based on probabilities, not conscious thought. 2. Ethical Concerns in AI Development A notable example discussed is Stanford University's controversial model to identify sexual orientation from photos, which raised ethical questions about the purpose and potential harm of such technologies. 3. Cultural Perspectives on Morals and AI Tomoko highlights how AI ethics are influenced by different societal morals. She shares insights into how cultural differences, such as religious restrictions on certain foods, impact perspectives on AI and technology. 4. Opportunities and Challenges of AI Opportunities include AI supporting aging societies, especially in Japan, and aiding healthcare through predictive analysis. However, the environmental cost of AI, such as energy consumption for data centers, presents significant challenges. 5. The Future of AI in Japan Japan aims to develop its own AI systems rather than relying on foreign technology. Tomoko discusses how open-source data initiatives can contribute to this goal while ensuring ethical development. 6. The Relationship Between AI and Humans Tomoko warns of potential isolation resulting from AI systems designed to cater to individual needs, and the danger of people avoiding real human interaction. However, she also sees AI’s potential to aid mental health by reducing trauma and depression. 7. AI Ethics and Interdisciplinary Dialogue The importance of engaging in dialogue across disciplines—engineers, sociologists, psychologists—is emphasized. Tomoko advocates for discussions about the societal impacts of AI, not just its technical development. Key Quotes: "Technology should support society, not the other way around." "AI is not sentient—it’s all about statistics, yet we often treat it as more." "The open-source approach can democratize AI development, but we must remain vigilant about its ethical use." Final Thoughts: Tomoko urges listeners to be more mindful of AI's social impact, emphasizing that understanding AI doesn't require a technical background. She encourages open-mindedness and the importance of interdisciplinary conversations to shape the future of AI responsibly.

    30 min

  2. 08/28/2024

    Culture and AI - with Tomoko Mitsuoka and Emir Mustafa Isler

    Overview: In this episode of the Delta Dialog, we talk about AI from a cultural and ethical perspective. Tomoko brings her unique insights, grounded in both Japanese and Western viewpoints, to explore how different cultural and religious beliefs influence the perception and development of artificial intelligence. Key Topics: 1. Cultural Differences in AI Perception Tomoko discusses how cultural background shapes people's understanding of AI. The influence of Japanese pop culture, particularly anime, has familiarized Japanese society with AI and robots, portraying them as human-like companions rather than threats. 2. Ethics and AI Regulation Tomoko suggests that while a neutral approach to AI design is preferable, cultural differences should be considered to create inclusive and effective regulations. The possibility of forming an international organization dedicated to AI governance was mentioned as a means to achieve a consensus on ethical standards globally. 3. Influence of Religion on AI Views Tomoko explains how in Shintoism, objects and nature are often imbued with spirits, leading to a more holistic and integrated approach to AI. Discussions include how religious beliefs shape ethical guidelines and influence public perception of AI, impacting the development and acceptance of AI technologies. 4. AI Literacy and Education Tomoko emphasizes the need for a well-informed society about AI. Bridging the gap between those with access to technology and those without is crucial for a more inclusive approach to AI literacy. 5. Impact of Pop Culture on AI Perception The portrayal of AI in Japanese anime versus Western media significantly shapes public attitudes. 6. The Concept of Tsukumogami and AI Tomoko introduces the concept of Tsukumogami, where objects cherished over time are believed to gain spirits. Conclusion: The episode concludes that understanding and respecting cultural perspectives are vital for developing ethical AI. By fostering global collaboration and enhancing AI literacy, societies can better prepare for AI's challenges and opportunities.

    32 min

  3. 08/19/2024

    AI and Biomarkers - with Marcus Ranney and Emir Mustafa Isler

    Overview: In this episode of Delta Dialog, we talk about what revolves around the rapidly evolving field of personalized health through biomarkers, the integration of AI, and the future of healthcare. Dr. Ranney shares his insights on how biomarkers, wearable devices, and large language models like BioGPT are transforming the way we approach health and longevity. Key Topics Discussed: 1. Introduction to Personalized Health: The role of biomarkers in biohacking and personalized health. The shift from episodic health checks to real-time, continuous health monitoring through wearable devices. 2. Technological Innovations in Healthcare: The impact of AI and large language models on healthcare. The potential of BioGPT and other AI models in improving health outcomes by interpreting large datasets. 3. Ethical Considerations in AI and Healthcare: Addressing bias in AI models, especially in diverse countries like India. The importance of creating region-specific AI solutions that consider cultural and biological differences. 4. Global Healthcare Perspectives: Comparing healthcare systems in the US, UK, and India. Challenges and opportunities in healthcare financing and sustainability. 5. Empowering Patients Through Technology: How digital biomarkers and personalized health protocols can empower patients to take charge of their health. The role of lifestyle changes and passive data collection in improving health outcomes. 6. Public Health Advocacy: The climate crisis as the most critical public health emergency. The need for collective action to address environmental impacts on health. 7. Advice for Aspiring Healthcare Professionals: Embracing curiosity and continuous learning as a career strategy. The importance of interdisciplinary collaboration in advancing healthcare. 8. Work-Life Harmony: Dr. Ranney's approach to balancing professional and personal life. The role of outdoor activities and family time in maintaining energy and enthusiasm. Final Remarks: Dr. Marcus Ranney emphasizes the importance of falling in love with the human body, highlighting it as the most incredible machine we possess. He encourages listeners to take care of their bodies to achieve amazing things.

    28 min

  4. 08/13/2024

    AI and Longevity - with Marcus Ranney and Emir Mustafa Isler

    Overview: In this episode of Delta Dialog, we engage in a thought-provoking conversation with Marcus Ranney, a seasoned professional in the healthcare and technology sectors. Marcus shares insights from his diverse career journey, which spans from expeditions in extreme environments to working with NASA and now focusing on longevity science. Key Discussion Points: 1. Introduction to Marcus Ranney: Marcus’s background as a medical practitioner and his early career in the Royal Air Force. His transition from the UK to Mumbai and how this move shaped his perspective on healthcare in India. 2. Journey into Longevity Science: The evolution of Marcus’s interest in longevity, influenced by his experience in extreme physiology and clinical medicine. His personal journey of recovery from COVID-19, which led him to a deeper understanding of functional lifestyle changes and their impact on healthspan. 3. The Human Edge Venture: Marcus elaborates on his venture, Human Edge, which leverages digital and blood biomarkers to create personalized health protocols. The concept of “Medicine 4P” - Preventative, Proactive, Personalized, and Participatory healthcare. 4. AI’s Role in Healthcare: The potential of AI to bridge healthcare gaps in India, especially in rural areas. Challenges in integrating AI into India’s healthcare system, including data privacy, regulation, and the accuracy of AI models. 5. Unique Personal Anecdotes: Marcus shares a quirky story about setting a Guinness World Record for backward running with his son, highlighting his love for unique challenges. His impactful work during the COVID-19 pandemic through the “Meds for More” initiative, which facilitated the donation and distribution of leftover medications to those in need. Conclusion: The episode wraps up with reflections on the lessons learned from the pandemic and the importance of community-driven initiatives. Marcus’s inspiring journey and innovative approaches to healthcare provide valuable insights into the future of health and wellness.

    26 min

  5. 08/07/2024

    Alzheimer's and AI - with Sara Moein and Emir Mustafa Isler

    Overview: In this episode of the Delta Dialog, we disuss the intersection of AI, machine learning, and healthcare. Sara, a researcher in the field, shares insights into how these technologies are applied to genetic and healthcare data to improve our understanding of diseases such as Alzheimer's and various types of cancer. Key Topics Discussed: 1. Introduction to Single Cell RNA Sequencing: Single cell RNA sequencing is a powerful tool for understanding disease mechanisms at the cellular level. It helps identify different cell types and subtypes within brain tissue, revealing the diversity of cells affected by Alzheimer’s disease. The technology is crucial for early detection of Alzheimer’s and other complex diseases by analyzing gene expression in individual cells. 2. Contributions of Single Cell RNA Sequencing to Alzheimer’s Research: Helps detect disease mechanisms through pathway analysis and identifying dysregulated pathways specific to Alzheimer’s. Provides insights into cell-specific gene expression profiles, aiding in the understanding of disease pathology. Detects unique molecular signatures and cellular interactions, which are essential for understanding the progression of Alzheimer’s and other diseases. 3. Early Diagnosis and Preclinical Studies: Single cell RNA sequencing can detect biomarkers with high accuracy, potentially identifying Alzheimer’s years before clinical symptoms appear. This early detection allows for the identification of therapeutic targets and the testing of drug responses at the cellular level. 4. Ethical Considerations in AI and Healthcare: Ensuring data privacy and security is a top priority. The importance of unbiased and fair data sampling to avoid skewed results. Addressing the broader social and economic impacts of AI research, such as job displacement and healthcare access disparities. 5. Handling Large Genetic and Healthcare Datasets: The role of GPUs and cloud storage solutions in processing and storing vast amounts of data. The evolution of deep neural networks and their application in AI research due to advancements in hardware technology. 6. Public Understanding of AI and Healthcare: Simplifying complex concepts for a non-technical audience by highlighting the practical benefits of AI in healthcare. Examples include AI in medical imaging, early diagnosis, and drug development. 7. Advice for Aspiring Researchers: Importance of building a strong foundation in both biology and computation. Developing technical skills in programming, data handling, and designing new algorithms. Continuously learning and staying updated with the latest advancements in machine learning and healthcare. 8. Recommended Resources and Channels: Following influential researchers and attending conferences. Utilizing platforms like Medium and LinkedIn for networking and staying informed. Reference books on statistical learning and machine learning as essential resources. Conclusion: Sara Moein shares valuable insights into how AI and machine learning are revolutionizing healthcare, particularly in the study of complex diseases like Alzheimer’s and cancer. The conversation underscores the importance of ethical considerations, continuous learning, and the need for public understanding of these advanced technologies.

    34 min

  6. 07/31/2024

    Alzheimer's and Machine Learning - with Sara Moein and Emir Mustafa Isler

    Overview: In this episode of the Delta Dialog, we delve into the significant impact of AI in healthcare, particularly focusing on disease prediction, diagnosis, and treatment. Key Points: 1. AI in Alzheimer's Disease: Use of Deep Neural Networks (DNNs) in differentiating between mild and severe Alzheimer's cases through brain imaging. Steps involved in data acquisition, preprocessing, feature extraction, and model validation. 2. Machine Learning Models in Alzheimer's Diagnosis: Enhancing accuracy and speed compared to traditional methods. Ability to analyze large, complex datasets including medical records, genetic information, and brain imaging. 3. Addressing Bias in Machine Learning Models: Techniques like cross-validation to ensure model accuracy and fairness. Importance of validating and testing models with unseen data to eliminate biases. 4. Machine Learning in Drug Development: Accelerating the discovery and development of new drugs. Predicting disease progression and treatment responses. Personalized medicine and evaluating drug efficacy using clinical trial data. 5. Genetic Associations and Disease: Identifying hidden associations between genetic defects and diseases like Alzheimer's. Integration of genomic, phenotypic, and environmental data. The role of feature engineering, supervised and unsupervised learning in understanding genetic profiles. Key Takeaways: AI and machine learning are revolutionizing the field of healthcare by improving diagnostic accuracy, speeding up drug development, and providing personalized treatment options. Techniques like DNNs and supervised/unsupervised learning are essential in managing and understanding complex diseases like Alzheimer's. Addressing bias and validating models are critical steps in ensuring the reliability of AI tools in clinical settings.

    29 min

  7. 07/23/2024

    Brainstorming Open Medical Data and AI - with Ahmad Nazzal and Emir Mustafa

    Overview: In this episode of the Delta Dialog, we explore the evolving landscape of open medical data and AI in healthcare. The conversation delves into the challenges and opportunities presented by AI, offering a comprehensive look at how these technologies are reshaping the medical field. Key Points: 1. Open Medical Data: Emphasizes the positive impact of open medical data. Highlights the importance of well-curated and accessible datasets for AI research and development. Discusses the AI community's open science mentality and its benefits for global healthcare. 2. AI in Patient Communication: Explains how large language models can help doctors translate complex medical information for patients. Reduces patient anxiety and improves comprehension through AI-generated explanations. Potential applications include AI-generated tutorials and digital nurses providing consistent information. 3. AI in Medical Education: Explores AI's transformative potential in training future healthcare professionals. Notes that medical students are already leveraging AI tools for studying and exam preparation. Advocates for integrating AI into medical curricula despite resistance from some academics. 4. Training for Current Professionals: Acknowledges challenges in convincing busy doctors to adopt new technologies. Suggests continuous medical education initiatives to help bridge the gap. Emphasizes understanding AI's limitations and advantages rather than fearing it. 5. Public Perception vs. Reality: Discusses the disparity between public perception and the reality of AI's capabilities. Cautions against humanizing AI, which can lead to unrealistic expectations and fear. Advocates for viewing AI as a powerful tool to enhance healthcare outcomes. 6. Advice for Aspiring Medical Writers and Professionals: Stresses the importance of continuous learning and reading extensively in the field. Highlights the need for developing strong writing skills and embracing AI tools. Encourages maintaining critical thinking and problem-solving abilities. 7. Future of AI in Healthcare: Expresses excitement about AI's potential to make healthcare more affordable and accessible. Envisions AI tools personalizing treatment, reducing errors, and improving patient outcomes. Emphasizes the necessity of collaboration between healthcare professionals and AI developers.

    30 min

  8. 07/16/2024

    Brainstorming AI and Healthcare - with Ahmad Nazzal and Emir Mustafa Isler

    In this episode of the Delta Dialog, we explore the dynamic intersection of AI and healthcare. Dr. Nazzal shares his journey from his early fascination with science and computers to his current work in digital health and AI, particularly in radiology and neuroscience. Key Points: 1. Introduction to Dr. Ahmad Nazzal: Background in digital health, data science, and clinical research. Current work on AI solutions for radiology with a German company. Focus on AI tools for better diagnosis of Alzheimer's and dementia. 2. Journey into AI and Medicine: Early interest in science and computers. Transition from computer engineering to medicine and neuroscience. PhD research at the Max Planck Institute on consciousness and decision-making. Initial exposure to AI through machine learning algorithms in neuroscience research. 3. Human Learning vs. Machine Learning: Differences between biological intelligence and machine learning. The role of statistical tools and algorithms in AI. The challenges and limitations of current AI systems. Importance of clear terminology to avoid public confusion and fear. 4. Recent Advancements and Future Implications: Discussion of OpenAI’s ChatGPT and its capabilities. Debate on AI’s perceived understanding versus actual sentience. The need for new tests to measure AI’s comprehension and capabilities. 5. AI’s Impact on Medical Practice: Potential to revolutionize healthcare by enhancing accuracy and efficiency. AI’s role in diagnostics, patient management, and clinical trials. Examples of AI’s contribution to developing new classes of antibiotics. Vision for a more personalized and patient-focused healthcare system. Quotable Moments: "AI is a statistical tool at the end of the day or a mathematical equation that helps you organize your data and make sense of whatever input you give it." "We need better tests to understand what's going on in these complex AI models." "AI will revolutionize healthcare by delivering accurate and unbiased results 24/7."

    26 min
See All (62)

About

DELTA DIALOG is a series of discussions and interviews on AI and technology as in its development, usage in different sectors and industries, and how it engages or better said changes the world. Together with experts from diverse industries, the show explores many perspectives regarding AI and technology that has everyday implications around the world.

Information

  • Creator
    Emir Mustafa Isler
  • Years Active
    2022 - 2024
  • Episodes
    62
  • Rating
    Clean
  • Copyright
    © Emir Mustafa Isler
  • Show Website
    DELTA DIALOG

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada